Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 13.15 M14.94 M14.11 M16.53 M17.61 M 63.19 M Research & development ————— — Operating income 94.54 M103.23 M105.81 M111.58 M125.5 M 446.13 M Non-Operating Income, Total -44.36 M-36.17 M-7.05 M-28.36 M-14.67 M -86.25 M Interest expense, net of interest capitalized 22.95 M22.63 M20.39 M19.81 M18.8 M 81.63 M Non-Operating Income, excl. Interest Expenses -22.64 M-23.2 M-20.51 M-20.25 M-18.09 M -82.05 M Unusual income/expense -44.67 M-35.61 M-6.93 M-27.91 M-15.38 M -85.83 M Pretax income -6.24 M10.81 M35.55 M8.53 M23.49 M 78.37 M Equity in earnings -1.85 M-1.24 M462 K657 K792 K 673 K Taxes 604 K732 K-21.09 M-2.42 M-525 K -23.3 M Non-controlling/minority interest -36 K171 K712 K165 K298 K 1.35 M After tax other income/expense ————— — Net income before discontinued operations -6.8 M9.91 M55.93 M10.78 M23.71 M 100.32 M Discontinued operations ————— — Net income -6.8 M9.91 M55.93 M10.78 M23.71 M 100.32 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -6.81 M9.91 M55.93 M10.78 M23.71 M 100.32 M Basic earnings per share (Basic EPS) -0.040.060.330.070.13 0.59 Diluted earnings per share (Diluted EPS) -0.040.060.330.070.13 0.59 Average basic shares outstanding 156.92 M160.5 M169.01 M166.06 M187.32 M — Diluted shares outstanding 156.92 M161.14 M169.8 M166.85 M187.97 M — EBITDA 79.55 M88.36 M91.66 M91.76 M105.93 M 377.7 M EBIT 38.43 M46.42 M42.48 M36.43 M38.87 M 164.2 M Cost of revenue 432.42 M426.29 M454.53 M480.29 M512.17 M 1.87 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 41.11 M41.94 M49.18 M55.32 M67.06 M 213.51 M